Endocrinologia e Metabologia

Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.

The lancet. Diabetes & endocrinology. 2026 Feb; 14(Feb):157-177. doi: 10.1016/S2213-8587(25)00335-3. pii: S2213-8587(25)00335-3.

Preanalytic Considerations for Preventing In Vitro Glycolysis: Practical Recommendations for Fasting and Glucose Tolerance Testing.

Diabetes care. 2026 Feb; 49(Feb):e24-e25. doi: 10.2337/dc25-2197. pii: .

What to Know About the WHO's New GLP-1 Drug Guideline.

JAMA. 2026 Feb; 335(Feb):388-390. doi: 10.1001/jama.2025.25208. pii: .

Use of a Best Practice Advisory to increase the detection rate of hyperparathyroidism.

Surgery. 2026 Jan; 189(Jan):109706. doi: 10.1016/j.surg.2025.109706. pii: S0039-6060(25)00558-6.

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S261-S276. doi: 10.2337/dc26-S012. pii: .

14. Children and Adolescents: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S297-S320. doi: 10.2337/dc26-S014. pii: .

16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S339-S355. doi: 10.2337/dc26-S016. pii: .

17. Diabetes Advocacy: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S356-S357. doi: 10.2337/dc26-S017. pii: .

A Review of Hypothyroidism.

JAMA. 2026 Feb; 335(Feb):461-462. doi: 10.1001/jama.2025.21660. pii: .

What Is Adrenal Insufficiency?

JAMA. 2026 Jan; doi: 10.1001/jama.2025.23130. pii: .

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

The New England journal of medicine. 2026 Mar; 394(Mar):947-957. doi: 10.1056/NEJMoa2512854. pii: .

11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050.

The lancet. Diabetes & endocrinology. 2026 Feb; 14(Feb):149-156. doi: 10.1016/S2213-8587(25)00299-2. pii: S2213-8587(25)00299-2.

Approach to the Patient - Transitions in Osteoporosis Therapy.

The Journal of clinical endocrinology and metabolism. 2026 Jan; 111(Jan):e577-e585. doi: 10.1210/clinem/dgaf614. pii: .

Approach to the Patient With Pancreatogenic Diabetes.

The Journal of clinical endocrinology and metabolism. 2026 Jan; 111(Jan):e569-e576. doi: 10.1210/clinem/dgaf623. pii: .

Reversal of Congenital Hypogonadotropic Hypogonadism.

The Journal of clinical endocrinology and metabolism. 2026 Jan; 111(Jan):e352-e361. doi: 10.1210/clinem/dgaf610. pii: .

Drug Repurposing for Reducing the Size of Benign Thyroid Nodules: A Systematic Review.

The Journal of clinical endocrinology and metabolism. 2026 Jan; 111(Jan):e327-e338. doi: 10.1210/clinem/dgaf616. pii: .

Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial.

The Journal of clinical endocrinology and metabolism. 2026 Jan; 111(Jan):341-347. doi: 10.1210/clinem/dgaf428. pii: .

Anti-obesity drugs: comprehensive review and emerging therapies.

Endocrine. 2026 Feb; 91(Feb):56. doi: 10.1007/s12020-025-04528-w. pii: .

The evolution of C-peptide's role in diabetes care.

Current opinion in endocrinology, diabetes, and obesity. 2026 Feb; 33(Feb):16-24. doi: 10.1097/MED.0000000000000947. pii: .

Diabetic Peripheral Neuropathy: New Diagnostics and Treatment Perspectives.

Drugs & aging. 2026 Jan; 43(Jan):29-48. doi: 10.1007/s40266-025-01267-5. pii: .

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis.

JAMA. 2026 Jan; 335(Jan):220-232. doi: 10.1001/jama.2025.20835. pii: e2520835.

Menopausal hormone treatment and breast cancer.

The lancet. Diabetes & endocrinology. 2026 Jan; doi: 10.1016/S2213-8587(25)00394-8. pii: S2213-8587(25)00394-8.

Tailoring transdermal estradiol dose to maximize benefits and minimize risks.

Menopause (New York, N.Y.). 2026 Jan; doi: 10.1097/GME.0000000000002723. pii: .

15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S321-S338. doi: 10.2337/dc26-S015. pii: .

13. Older Adults: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S277-S296. doi: 10.2337/dc26-S013. pii: .

11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S246-S260. doi: 10.2337/dc26-S011. pii: .

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S216-S245. doi: 10.2337/dc26-S010. pii: .

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2026.

Diabetes care. 2026 Jan; 49(Jan):S183-S215. doi: 10.2337/dc26-S009. pii: .

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults.

JAMA. 2026 Feb; 335(Feb):434-438. doi: 10.1001/jama.2025.24288. pii: .

Executive Summary of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association. 2025 Nov; 35(Nov):1214-1220. doi: 10.1177/10507256251390877. pii: .

International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood.

Endocrine reviews. 2023 May; 44(May):539-565. doi: 10.1210/endrev/bnad002. pii: .

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.

JAMA. 2025 Feb; 333(Feb):498-508. doi: 10.1001/jama.2024.27154. pii: .

Position statement on macroprolactinemia from the Department of Neuroendocrinology of the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC/ML).

Archives of endocrinology and metabolism. 2025 Nov; 69(Nov):e250152. doi: 10.20945/2359-4292-2025-0152. pii: e250152.

American Association of Clinical Endocrinology Consensus Statement: Algorithm for Management of Adults with Dyslipidemia - 2025 Update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Oct; 31(Oct):1207-1238. doi: 10.1016/j.eprac.2025.07.014. pii: S1530-891X(25)00972-3.

Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults.

European journal of endocrinology. 2025 Oct; 193(Oct):G49-G78. doi: 10.1093/ejendo/lvaf222. pii: .

Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women.

Clinical endocrinology. 2025 Oct; 103(Oct):540-566. doi: 10.1111/cen.15265. pii: .

2025 ACC Scientific Statement on the Management of Obesity in Adults With Heart Failure: A Report of the American College of Cardiology.

Journal of the American College of Cardiology. 2025 Nov; 86(Nov):1953-1975. doi: 10.1016/j.jacc.2025.05.008. pii: S0735-1097(25)06481-2.

Management of patients with type 2 diabetes and MASLD: An overview and joint statement.

Diabetes & metabolism. 2025 Oct; 51(Oct):101709. doi: 10.1016/j.diabet.2025.101709. pii: S1262-3636(25)00103-X.

Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement.

The Journal of clinical endocrinology and metabolism. 2025 Aug; 110(Aug):2496-2508. doi: 10.1210/clinem/dgaf267. pii: .

European society of endocrinology clinical practice guideline for evaluation and management of menopause and the perimenopause.

European journal of endocrinology. 2025 Sep; 193(Sep):G49-G81. doi: 10.1093/ejendo/lvaf206. pii: .

A multi-society Delphi consensus statement on the diagnosis of familial chylomicronemia syndrome.

Archives of endocrinology and metabolism. 2025 Sep; 69(Sep):e250071. doi: 10.20945/2359-4292-2025-0071. pii: .

Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism. 2025 Aug; 110(Aug):2453-2495. doi: 10.1210/clinem/dgaf284. pii: .

Consensus on acromegaly therapeutic outcomes: an update.

Nature reviews. Endocrinology. 2025 Aug; doi: 10.1038/s41574-025-01148-2. pii: .

Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism. 2025 Aug; 110(Aug):2405-2452. doi: 10.1210/clinem/dgaf288. pii: .

2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.

Thyroid : official journal of the American Thyroid Association. 2025 Aug; 35(Aug):841-985. doi: 10.1177/10507256251363120. pii: .

X-Linked Hypophosphatemia Management in Adults: An International Working Group Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism. 2025 Jul; 110(Jul):2353-2370. doi: 10.1210/clinem/dgaf170. pii: .

Multiple endocrine neoplasia type 1 (MEN1): recommendations and guidelines for best practice.

The lancet. Diabetes & endocrinology. 2025 Aug; 13(Aug):699-721. doi: 10.1016/S2213-8587(25)00119-6. pii: S2213-8587(25)00119-6.

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association.

Diabetes care. 2025 Jul; 48(Jul):1057-1082. doi: 10.2337/dci24-0094. pii: .

Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.

Thyroid : official journal of the American Thyroid Association. 2008 Mar; 18(Mar):333-46. doi: 10.1089/thy.2007.0315. pii: .

Consensus on the key characteristics of metabolism disruptors.

Nature reviews. Endocrinology. 2025 Apr; 21(Apr):245-261. doi: 10.1038/s41574-024-01059-8. pii: .

Managing obesity in children: a clinical practice guideline.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2025 Apr; 197(Apr):E372-E389. doi: 10.1503/cmaj.241456. pii: .

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025.

Diabetes care. 2025 Jan; 48(Jan):S181-S206. doi: 10.2337/dc25-S009. pii: .

American Association of Clinical Endocrinology Clinical Practice Guideline on Pharmacologic Management of Adults With Dyslipidemia.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2025 Feb; 31(Feb):236-262. doi: 10.1016/j.eprac.2024.09.016. pii: S1530-891X(24)00691-8.

Propionate Enhances the Browning of Adipose Mesenteric Tissue, Reduces Inflammation, and Increases Thermogenic Activity.

The Journal of clinical endocrinology and metabolism. 2026 Mar; 111(Mar):e1205-e1206. doi: 10.1210/clinem/dgaf368. pii: .

Finerenone in Type 1 Diabetes and Chronic Kidney Disease.

The New England journal of medicine. 2026 Mar; 394(Mar):947-957. doi: 10.1056/NEJMoa2512854. pii: .

What Is Hypothyroidism?

JAMA. 2026 Mar; 335(Mar):830. doi: 10.1001/jama.2025.19536. pii: .

Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors.

The Journal of clinical endocrinology and metabolism. 2026 Feb; 111(Feb):698-706. doi: 10.1210/clinem/dgaf498. pii: .

Approach to the Patient: Clinical Outcomes and Interim Strategies Following Discontinuation of Incretin Agonists.

The Journal of clinical endocrinology and metabolism. 2026 Feb; 111(Feb):870-878. doi: 10.1210/clinem/dgaf641. pii: .

A Review of Hypothyroidism.

JAMA. 2026 Feb; 335(Feb):461-462. doi: 10.1001/jama.2025.21660. pii: .

World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults.

JAMA. 2026 Feb; 335(Feb):434-438. doi: 10.1001/jama.2025.24288. pii: .

What to Know About the WHO's New GLP-1 Drug Guideline.

JAMA. 2026 Feb; 335(Feb):388-390. doi: 10.1001/jama.2025.25208. pii: .

Anti-obesity drugs: comprehensive review and emerging therapies.

Endocrine. 2026 Feb; 91(Feb):56. doi: 10.1007/s12020-025-04528-w. pii: .

Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement.

The lancet. Diabetes & endocrinology. 2026 Feb; 14(Feb):157-177. doi: 10.1016/S2213-8587(25)00335-3. pii: S2213-8587(25)00335-3.